TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: PD and CAL reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding self-efficacy levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Newborn weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted prevalence of rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted prevalence of allergic conjunctivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted prevalence of eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ejection fraction recovery at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Mean final pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle force for isokinetic contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: treatment adherence rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: deflection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Survivorship of the HemiCAP® PFC implant
Endpoint domain: Mortality/survival
Primary endpoint: oral yeasts colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leg FFM increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 1-RM increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Orbital lesion conspicuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Details of internal structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 infection diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: number of laboratory-confirmed COVID-19 cases
Endpoint domain: Mortality/survival
Primary endpoint: implant stability at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: external rotator strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Health (GH) values
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional Assessment of Chronic Illness Therapy (FACIT)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Care burden scores
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: 1-year DFS rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean direct healthcare costs per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean 12-month QALYs per patient
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reliable symptomatic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation or intensification of GDMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of sacral pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Days of using vasopressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of fluid administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in LVEF to >35%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful CRRT liberation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RRT-free survival at hospital discharge
Endpoint domain: Mortality/survival
Primary endpoint: Mean subjective International Knee Documentation Committee score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lateral tibiofemoral osteoarthritis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in ESS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HFPSE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multiple-choice reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of cerebral events
Endpoint domain: Mortality/survival
Primary endpoint: QFR value after DCB angioplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MCA Vmean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PCA Vmean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of spoken language impairments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of social impairments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100‐β levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: post-oral glucose tolerance test (OGTT) glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fual-Meger (FMA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological system outcomes
Primary endpoint: Neurological deficit (ND) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neonatal gut microbiome alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of stay in PACU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Palatal tipping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: healing rate of diabetic foot ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional functioning scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning
Primary endpoint: Step frequency and speed improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of anterior tibial muscle improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean half-life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of transferred embryos resulting in a live born baby
Endpoint domain: Mortality/survival
Primary endpoint: visfatin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: fasting glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: glycosylated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Identification of fraudulent or ineligible enrollments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: HRQOL improvements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: histological complete resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Grade≥3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants appropriately choosing to quarantine after a positive test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants failing to quarantine appropriately after a negative test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants choosing unnecessary quarantine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean exotropia control score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean near stereoacuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin sensitivity (Quicki)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mood recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High thirst level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recent colorectal investigations for screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated EC50 of sevoflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to wakefulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: dorsiflexor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MQSGA scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Affective valence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VSI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of residual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body image concern
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Left ventricular size and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HA levels measured with Vectra H2®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PDQS (Pregnancy Diet Quality Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hs-CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incentive motivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-suicidal self-injury (NSSI) incidents at post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clearance of viral warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VAS for abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients meeting discharge criteria
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Descending pain modulation CPM responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight change at 8 weeks' gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of administration of 166Ho microspheres
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumour dosimetry success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CTCAE grade 3-4 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: greater proportion of day-case procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Child mental health improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of careworker caregiving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Herpes zoster rates
Endpoint domain: Adverse events/effects
Primary endpoint: FES-I scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in mean VAS score for pelvic pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in BMD from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful overall bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Perfect overall bowel preparation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: High-quality bowel preparations for the right colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: serious cardiovascular events
Endpoint domain: Adverse events/effects
Primary endpoint: cancer-related events
Endpoint domain: Adverse events/effects
Primary endpoint: hip pain intensity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulmonary contusion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient‐Rated Wrist Evaluation total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean loading force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean inspiratory pressure (Pmean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of knee ROA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of post-operative pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return to activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Undergoing appendectomy within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Mean differences in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CRP levels at postoperative 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCT levels at postoperative 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to very low nicotine content cigarettes (VLNC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma IL-10 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proinflammatory cytokine IFN-γ-induced protein 10 release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bacterial dissemination to the spleen, liver, and blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean bias for OpenPose and MSRA method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficients for body position accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful EEG recorded
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: abnormal EEG detected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total direct cost incurred
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: joint mobility functions during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥50% reduction in the NRS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from first oral feeding to full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hypersensitivity/pain values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child health behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with at least 1 adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Vein graft occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients achieving primary end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean arterial pressure (MAP) recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nanoleakage (NL) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive worsening (Preclinical Alzheimer Cognitive Composite)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive worsening (Repeatable Battery for the Assessment of Neuropsychological Status)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neuropsychiatric treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: functional health literacy skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feelings of connectedness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: stages of tenosynovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTP rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODK rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in plaque volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: decrease in percent necrotic volumes (%NV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: decrease in percent plaque volume (%PV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Quadriceps contractile function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POMS-fatigue ratings
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Quadriceps muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time of lactation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 48-hour postpartum lactation volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of anti-glaucoma medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Exercise ventilation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance impairment in acute hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency of trial design
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Anxiety levels in dental patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV testing uptake and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: core intraoperative temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients remaining adjudicated relapse-free
Endpoint domain: Mortality/survival
Primary endpoint: Adjudicated annualized relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved overall cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFC Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness in preventing heartworm development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult D. immitis counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ECST for TB detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of ECST for TB detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between ECST and T‐SPOT.TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RDL reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P-SIM items assessing key symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of Life (QoL) total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: THDC malfunction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self-control over drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Severity Index ratings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Need for fellow eye injection
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean time to treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to cecal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to relapse of depression
Endpoint domain: Mortality/survival
Primary endpoint: Utility scores at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality-adjusted life-years over 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: lower craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean treatment acceptability scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status